e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Methodological considerations in noninvasive assessment of airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate
E. Tufvesson, L. Bjermer (Lund, Sweden)
Source:
Annual Congress 2005 - Methodological considerations in noninvasive assessment of airway inflammation
Session:
Methodological considerations in noninvasive assessment of airway inflammation
Session type:
Thematic Poster Session
Number:
2402
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Tufvesson, L. Bjermer (Lund, Sweden). Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Eur Respir J 2005; 26: Suppl. 49, 2402
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Early detection of lung cancer in exhaled breath condensate using miRNA markers
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients?
FEV
1
dynamics and total NO
3
-/ NO
2
- level in exhaled breath condensate of current smokers
Related content which might interest you:
Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002
Technical problems with measurements of biomarkers - exhaled breath condensate
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Exhaled breath condensate: 8-isoprostane and eicosanoids
Source: Eur Respir Monogr 2010; 49: 196-206
Year: 2010
Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007
Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 680s
Year: 2004
Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1036-1041
Year: 2006
Cytokines in exhaled breath condensate of patients with asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008
Inflammatory mediators in exhaled breath condensate, induced sputum and saliva
Source: Eur Respir J 2004; 24: Suppl. 48, 678s
Year: 2004
Correlation of LTB
4
with α-amylase in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005
Reproducibility of cysteinyl-leukotriene measurements in exhaled breath condensate in children
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001
Profile of prostanoids in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 400s
Year: 2003
Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010
Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004
Endogenous and exogenous metabolites in exhaled breath condensate in asthma
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Reproducibility of exhaled breath condensate markers
Source: Eur Respir J 2008; 32:
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept